Adrenal cortical tumors, pheochromocytomas and paragangliomas

Modern Pathology

Volumn 24, Issue SUPPL. 2, 2011, Pages

  Lloyd, Ricardo V ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

adrenal cortical adenoma; adrenal cortical carcinoma; paraganglioma; pheochromocytoma; succinic dehydrogenase mutations

Indexed keywords

CHROMOGRANIN; CYCLOOXYGENASE 2; EM66 PROTEIN; HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 2ALPHA; NERVE CELL ADHESION MOLECULE; PROTEIN; PROTEIN S 100; SYNAPTOPHYSIN; TELOMERASE REVERSE TRANSCRIPTASE; TENASCIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CHROMAFFIN CELL; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MITOSIS RATE; MULTIPLE ENDOCRINE NEOPLASIA; NECROSIS; NEUROFIBROMATOSIS; PARAGANGLIOMA; PARASYMPATHETIC NERVE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; STAINING; SYMPATHETIC NERVE; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

EID: 79953327107     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.126     Document Type: Article

References (53)

1. DeLellis RA, Lloyd RV, Heitz PU, et al. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Endocrine Organs. IARC Press: Lyon, France 2004;137-146.
2. King DR, Lack EE. Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 1979;44:239-244. (Pubitemid 9234938)
3. Symington T. The adrenal cortex. In: Symington T (ed). Functional Pathology of the Human Adrenal Glands. Williams & Wilkins: Baltimore, 1969;3-216.
4. Tang CK, Harriman BB, Toker C. Myxoid adrenal cortical carcinoma: a light and electron microscopic study. Arch Pathol Lab Med 1979;103:635-638. (Pubitemid 10189504)
5. Sasano H, Suzuki T, Sano T, et al. Adrenocortical oncocytoma. A true non-functioning adrenocortical tumor. Am J Surg Pathol 1991;15:949-956.
6. Gaffey MJ, Traweek ST, Mills SE, et al. Cytokeratin expression in adrenocortical neoplasia: an immuno-histochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. Hum Pathol 1992;23:144-153.
7. Medeiros LJ, Weiss LM. New developments in the pathologic diagnosis of adrenal cortical neoplasm. A review. Am J Clin Pathol 1992;97:73-83.
8. Weiss LM. Comparative histologic study of 43 metas-tasizing and non-metastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-169. (Pubitemid 14166767)
9. Lau SK, Weiss LM. The Weiss system for evaluating adenocortical neoplasms: 25 years later. Hum Pathol 2009;40:757-768.
10. Aubert S, Waremier A, Leroy X, et al. Weiss system revisited. A clinicopathologic and immunohistochem-ical study of 49 adrenocortical tumors. Am J Surg Pathol 2002;26:1612-1619. (Pubitemid 35387224)
11. Van Slooten H, Schaberg A, Smeenk D, et al. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 1985;55:766-773. (Pubitemid 15173514)
12. Hough AJ, Hollifield JW, Page DL, et al. Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol 1979;72:390-399. (Pubitemid 10231372)
13. Suzuki T, Sasano H, Nisikawa T, et al. Discerning malignancy in human adrenocortical neoplasm: utility of DNA flow cytometry and immunohistochemistry. Mod Pathol 1992;4:224-231.
14. Goldblum JR, Shannon R, Kaldjian EP, et al. Immuno-histochemical assessment of proliferative activity in adrenocortical neopolasm. Mod Pathol 1993;6:663-668. (Pubitemid 2014262)
15. Kumar D, Kumar S. Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immuno-histochemical and DNA ploidy analysis. Mod Pathol 1993;6:36-41.
16. Schrider S, Niendorf A, Achilles E, et al. Immunocy-tochemical differential diagnosis of adrenocortical neoplasm using the monoclonal antibody D11. Virchows Arch 1990;417:89-96. (Pubitemid 20204360)
17. Tartour E, Caillou B, Tenenbaum F, et al. Immunohis-tochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody. Cancer 1993;72:3296-3303. (Pubitemid 23356776)
18. Wick MR, Cherwitz DL, McGlennen RC, et al. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma. Am J Pathol 1986;122:343-352. (Pubitemid 16121698)
19. Vargas MP, Vargas HI, Kleiner DE, et al. Adrenocortical neoplasm: role of prognostic markers MIB-1, P53 and RB. Am J Surg Pathol 1997;21:556-562. (Pubitemid 27213070)
20. Sasano H, Suzuki T, Nagura H, et al. Steroidogenesis in human adrenocortical carcinoma: biochemical activities, immunohistochemistry, and in situ hybridization of steroidogenic enzymes and histopathologic study in nine cases. Hum Pathol 1993;24:397-404. (Pubitemid 23127256)
21. Sasano H, Shizawa S, Suzuki T, et al. Ad4BP in the human adrenal cortex and its disorders. J Clin Endocrinol Metab 1995;80:2378-2380.
22. Wieneke JA, Thompson LD, Heffess CS. Adrenal cortical neoplasm in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol 2003;27:867-881. (Pubitemid 36758889)
23. El-Naggar AK, Evans DB, Mackay B. Oncocytic adrenal cortical carcinoma. Ultrastruct Pathol 1991;15: 549-556.
24. Biscegha M, Ludovico O, Di Mattia A, et al. Adrenal oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 2004;12:231-243. (Pubitemid 39063350)
25. Brown FM, Gaffey TA, Wold LE, et al. Myxoid neoplasms of the adrenal cortex: a rare histologic variant. Am J Surg Pathol 2000;24:396-401. (Pubitemid 30127475)
26. Erickson LS, Jin L, Sebo TJ, et al. Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasm. Endocr Pathol 2001;12: 429-435. (Pubitemid 34274396)
27. Stojadinuvic A, Ghossein RA, Hous A, et al. Adreno-cortical carcinoma: clinical, morphologic and molecular characterization. J Clin Oncol 2002;20:941-950.
28. Giordano TJ, Thomas DG, Kuick R, et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 2003;162:521-531. (Pubitemid 36267859)
29. Giordano TJ. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas. Endocr Pathol 2006;17:355-364.
30. Velazquez-Fernandez D, Laurell C, Geli J, et al. Expression profiling of adrenal cortical neoplasms suggest a molecular signature of malignancy. Surgery 2005;138:1087-1094. (Pubitemid 41797349)
31. Suh I, Guerrero MA, Kebebew E. Gene-expression profiling of adrenocortical carcinoma. Expert Rev Mol Diagn 2009;9:343-351. Review.
32. Melicow MM. One hundred cases of pheochromocy-toma (107 tumors) at the Columbia- Presbyterian Medical Center, 1926-1976: a clinicopathological analysis. Cancer 1977;40:1987-2004. (Pubitemid 8239681)
33. Modlin IM, Farndon JR, Shephers A, et al. Pheochro-mocytomas in 72 patients: clinical and diagnostic features, treatment and long term results. Br J Surg 1979;66:456-465. (Pubitemid 10233598)
34. Kimura N, Watanabe T, Noshiro T, et al. Histological grading of adrenal and extra-adrenal pheochromocy-tomas and relationship to prognosis: a clinicopatholo-gical analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 2005;16:23-32. (Pubitemid 41278311)
35. Linnoila RI, Keiser HR, Steinberg SM, et al. Histo-pathology of benign versus malignant sympathoadre-nal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 1990;21:1168-1180. (Pubitemid 20382001)
36. Favier J, Plouin PF, Corvol P, et al. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 2002;161: 1235-1246.
37. Rooijens PP, de Krijger RR, Bonjer HJ, et al. The significance of angiogenesis in malignant pheochro-mocytomas. Endocr Pathol 2004;15:39-45.
38. Eisenhofer G, Bornstein SR, Brouwers FM, et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 2004;11:423-436. (Pubitemid 39331275)
39. Allibhai Z, Rodrigues G, Brecevic E, et al. Malignant pheochromocytomas associated with germline mutation of the SDHB gene. J Urol 2004;172:1409-1410. (Pubitemid 39249731)
40. Pang LC, Tsao KC. Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytomas or paraganglio-mas. Arch Pathol Lab Med 1993;117:1142-1147.
41. Bertherat J, Gimenez-Roqueplo AP. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. Horm Metab Res 2005;37: 384-390. (Pubitemid 41008774)
42. Bravo EL. Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr Rev 1994;15:356-368. (Pubitemid 24180793)
43. Shapiro B, Sisson JC, Lloyd R, et al. Malignant pheochromocytoma: clinical, biochemical and scinti-graphic characterization. Clin Endocrinol (Oxf) 1984; 20:189-203. (Pubitemid 14177191)
44. Pattarino F, Bouloux PM. The diagnosis of malignancy in pheochromocytoma. Clin Endocrinol (Oxf) 1996; 44:2390241.
45. Plouin PF, Chatelier G, Fofol I, et al. Tumor recurrence and hypertension persistence after successful pheochromo-cytoma operation. Hypertension 1997;29:1133-1139. (Pubitemid 27198222)
46. Thompson LD. Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immu-nophenotypic study of 100 cases. Am J Surg Pathol 2002;26:551-566. (Pubitemid 34438716)
47. Wu D, Tischler AS, Lloyd RV, et al. Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. Am J Surg Pathol 2009;33:599-608.
48. Gao B, Meng F, Bien W, et al. Validation of Pheochro-mocytomas of the Adrenal Gland Scaled Score for predicting malignant pheochromocytomas. Urology 2006;68:282-286. (Pubitemid 44175483)
49. Tischler AS, Kimmura N, McNicol AM. Pathology of pheochromocytoma and extra-adrenal paraganglioma. Ann NY Acad Sci 2006;1073:557-576.
50. Zarheger R, Kebebew E, Duh Y-Y, et al. Malignant pheochromocytoma. Surg Oncol Clin N Am 2006;15: 555-571. (Pubitemid 44150593)
51. Dannenberg H, Komminoth P, Dinjens WNM, et al. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas. En-docr Pathol 2003;14:329-350. (Pubitemid 38903386)
52. Hao H-X, Khalimonchuk O, Shraders M, et al. SDH5 a gene required for flavinatin of succinate dehydrogen-ase, is mutated in paraganglioma. Science 2009;325: 1139-1142.
53. van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC and SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 2009;10:764-777.